biotech · Chronic Hepatitis b · Hepatitis B, Chronic · ABUS
Arbutus Biopharma
Arbutus Biopharma Corp
Arbutus Biopharma patent portfolio — 56 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 701 Veterans Circle, Warminster, Pennsylvania 18974, US
- Employees
- 49
- Programs
- 13
- Drugs
- 7
- Patents
- 56
Arbutus Biopharma patents
56 pharmaceutical patents indexed for Arbutus Biopharma. 0 expire within 24 months.
Arbutus Biopharma has 56 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 9764036
Lipids and compositions for the delivery of therapeutics
granted -
US 9707292
Lipids and compositions for the delivery of therapeutics
granted -
US 9694077
Lipid compositions
granted -
US 9687550
Compositions for nucleic acid delivery
granted -
US 9682139
Lipids and compositions for the delivery of therapeutics
granted -
US 9636301
In vitro release assay for liposome encapsulated vincristine
granted -
US 9533990
Inhibitors of secretion of hepatitis B virus antigens
granted -
US 9394234
Lipid formulations
granted
Frequently asked questions
How many patents does Arbutus Biopharma have?
56 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Arbutus Biopharma patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.